JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB226972

Anti-Cyclin D2 antibody - N-terminal

Be the first to review this product! Submit a review

|

(4 Publications)

Rabbit Polyclonal Cyclin D2 antibody. N-terminal. Suitable for WB, IHC-P, ICC/IF and reacts with Human samples. Cited in 4 publications. Immunogen corresponding to Synthetic Peptide within Human CCND2.

View Alternative Names

G1/S-specific cyclin-D2, CCND2

3 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Cyclin D2 antibody - N-terminal (AB226972)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Cyclin D2 antibody - N-terminal (AB226972)

Paraffin-embedded human cervical carcinoma tissue stained for Cyclin D2 using ab226972 at 1/500 dilution in immunohistochemical analysis.

Immunocytochemistry/ Immunofluorescence - Anti-Cyclin D2 antibody - N-terminal (AB226972)
  • ICC/IF

Supplier Data

Immunocytochemistry/ Immunofluorescence - Anti-Cyclin D2 antibody - N-terminal (AB226972)

4% paraformaldehyde-fixed HeLa (human epithelial cell line from cervix adenocarcinoma) cells labeling Cyclin D2 (green) using ab226972 at 1/500 dilution in ICC/IF. Nuclear counterstained with Hoechst 33342.

Western blot - Anti-Cyclin D2 antibody - N-terminal (AB226972)
  • WB

Supplier Data

Western blot - Anti-Cyclin D2 antibody - N-terminal (AB226972)

12% SDS-PAGE gel.

All lanes:

Western blot - Anti-Cyclin D2 antibody - N-terminal (ab226972) at 1/1000 dilution

All lanes:

RD whole cell extract at 30 µg

Predicted band size: 33 kDa

false

Key facts

Host species

Rabbit

Clonality

Polyclonal

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

IHC-P, ICC/IF, WB

applications

Immunogen

Synthetic Peptide within Human CCND2. The exact immunogen used to generate this antibody is proprietary information.

P30279

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "", "WB-species-notes": "<p></p>", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/100 - 1/1000", "IHCP-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/100 - 1/1000", "ICCIF-species-notes": "<p></p>" } } }

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Immunogen
Storage buffer
pH: 7 Preservative: 0.025% Proclin 300 Constituents: PBS, 20% Glycerol (glycerin, glycerine)
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Regulatory component of the cyclin D2-CDK4 (DC) complex that phosphorylates and inhibits members of the retinoblastoma (RB) protein family including RB1 and regulates the cell-cycle during G(1)/S transition (PubMed : 18827403, PubMed : 8114739). Phosphorylation of RB1 allows dissociation of the transcription factor E2F from the RB/E2F complex and the subsequent transcription of E2F target genes which are responsible for the progression through the G(1) phase (PubMed : 18827403, PubMed : 8114739). Hypophosphorylates RB1 in early G(1) phase (PubMed : 18827403, PubMed : 8114739). Cyclin D-CDK4 complexes are major integrators of various mitogenenic and antimitogenic signals (PubMed : 18827403, PubMed : 8114739).
See full target information CCND2

Publications (4)

Recent publications for all applications. Explore the full list and refine your search

Frontiers in oncology 10:620306 PubMed33614501

2021

A Novel Androgen-Induced lncRNA FAM83H-AS1 Promotes Prostate Cancer Progression the miR-15a/CCNE2 Axis.

Applications

Unspecified application

Species

Unspecified reactive species

Bo Liu,Duocheng Qian,Weidong Zhou,Huiyang Jiang,Zhendong Xiang,Denglong Wu

Cancers 12: PubMed32784654

2020

Human FBXL8 Is a Novel E3 Ligase Which Promotes BRCA Metastasis by Stimulating Pro-Tumorigenic Cytokines and Inhibiting Tumor Suppressors.

Applications

Unspecified application

Species

Unspecified reactive species

Shu-Chun Chang,Wayne Hsu,Emily Chia-Yu Su,Chin-Sheng Hung,Jeak Ling Ding

Molecular therapy. Nucleic acids 16:257-271 PubMed30925453

2019

lncRNA TUG1 Promotes Cisplatin Resistance by Regulating CCND2 via Epigenetically Silencing miR-194-5p in Bladder Cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Gan Yu,Hui Zhou,Weimin Yao,Lirong Meng,Bin Lang

Journal of experimental & clinical cancer research 37:230 PubMed30227870

2018

miR-4317 suppresses non-small cell lung cancer (NSCLC) by targeting fibroblast growth factor 9 (FGF9) and cyclin D2 (CCND2).

Applications

Unspecified application

Species

Unspecified reactive species

Xi He,Si-Yuan Chen,Zhao Yang,Jie Zhang,Wei Wang,Mei-Yue Liu,Yi Niu,Xiao-Mei Wei,Hong-Min Li,Wan-Ning Hu,Guo-Gui Sun
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com